Size-Dependent Tumor Penetration and in Vivo Efficacy of Monodisperse Drug–Silica Nanoconjugates
Year: 2013
Type: article
Abstract: The size of a nanomedicine strongly correlates with its biodistribution, tissue penetration, and cell uptake. However, there is limited understanding how the size of nanomedicine impacts the overall antitumor efficacy. We designed and synthesized camptothecin-silica nanoconjugates (Cpt-NCs) with monodisperse particle sizes of 50 and 200 nm, two representative sizes commonly used in drug delivery, and evaluated their antitumor efficacy in murine tumor models. Our studies revealed that the 50 nm Cpt-NC showed higher anticancer efficacy than the larger analogue, due presumably to its faster cellular internalization and more efficient tumor accumulation and penetration. Our findings suggest that nanomedicine with smaller sizes holds great promise for improved cancer therapy.
Source: Molecular Pharmaceutics
DOI: 10.1021/mp300684a
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
Awards: Training the Next Generation of Researchers in Cancer Nanotechnology at the NCI M, Developing Clinically Applicable, Cancer-Targeting Polymeric Nanoconjugates, G4778635926, Camptothecin-Containing Nanoparticles: Control Over Particle Size, Biodistributio, Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
OpenAlex ID: W2107481969
